CXApp Inc. 8-K

What Happened
CXApp Inc. (CXAI) filed an 8-K reporting that Nasdaq notified the company on Sept. 11, 2025 that its closing bid price had been below the $1.00 minimum required for continued listing. After failing to regain compliance by the initial March 10, 2026 deadline, Nasdaq granted a second 180-calendar-day extension on March 11, 2026, giving CXApp until Sept. 7, 2026 to meet the rule.

Key Details

• Nasdaq first sent a Minimum Bid Price Notice on Sept. 11, 2025 for a closing bid price under $1.00 for 30 consecutive business days.
• The original 180-day cure period expired on March 10, 2026 without the company regaining compliance.
• Nasdaq issued an Extension Notice on March 11, 2026, providing an additional 180 days (until Sept. 7, 2026) to have the closing bid price ≥ $1.00 for at least 10 consecutive trading days.
• Nasdaq allowed the extension because CXApp met other listing standards (market value of publicly held shares and other initial listing requirements); the company said it may effect a reverse stock split if necessary.

Why It Matters
This notice signals a risk to CXApp’s continued Nasdaq listing if the stock price stays below $1.00. The shares remain listed and tradable for now, but if the company cannot show compliance by Sept. 7, 2026 Nasdaq may delist the stock (though CXApp could appeal). Investors should monitor the company’s stock price, any corporate actions (such as a reverse stock split), and company updates about efforts to regain compliance. Compliance or failure to comply can affect liquidity, investor perception, and where the stock trades.